lombardi comprehensive cancer center

Studying the metabolome of smokers, Lombardi researchers find ea...

EurekAlert! - Cancer  Sat, 11/06/2010 - 22:00

(Georgetown University Medical Center) Examining the blood "metabolomics" profile of smokers immediately after they had a cigarette revealed activation of pathways involved in cell death, inflammation, and other forms of systemic damage, say researchers at Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center.


 

Susan G. Komen for the Cure awards grant to Lombardi's V. Craig ...

EurekAlert! - Medicine and Health  Sun, 06/06/2010 - 22:00

(Georgetown University Medical Center) Susan G. Komen for the CureĀ® has appointed V. Craig Jordan, OBE, Ph.D., D.Sc., F.Med.Sci., to its Scientific Advisory Council.

Jordan, a member of the National Academy of Sciences, is the scientific director and vice chairman of the department of oncology at the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center.


 

Lombardi receives $7.5 million grant for Breast Cancer Center fo...

EurekAlert! - Medicine and Health  Sun, 03/21/2010 - 22:00

(Georgetown University Medical Center) Scientists at the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center were awarded a five-year $7.5 million grant to tease apart -- in the most comprehensive way ever devised -- the role of a single protein receptor in breast cells in cancer development and treatment.

This protein determines which women will develop the most common kind of breast cancer and how she will fare during her treatment.


 

New research could advance research field critical to personaliz...

EurekAlert! - Medicine and Health  Mon, 12/28/2009 - 23:00

(Georgetown University Medical Center) It's the ultimate goal in the treatment of cancer: tailoring a person's therapy based on his or her genetic makeup.

While a lofty goal, scientists are steadily moving forward, rapidly exploiting new technologies. Researchers at Georgetown Lombardi Comprehensive Cancer Center report a significant advance in this field of research using a new chip that looks for hundreds of mutations in dozen of genes.


 

Antibody targeting of glioblastoma shows promise in preclinical ...

EurekAlert! - Cancer  Wed, 07/29/2009 - 22:00

(Georgetown University Medical Center) Cancer researchers at Georgetown University's Lombardi Comprehensive Cancer Center have successfully tested a small, engineered antibody they say shuts down growth of human glioblastoma tumors in cell and animal studies.

Glioblastoma is the deadliest of brain cancers; there is no effective treatment.


 

Dual role in breast tissue for a protein involved in leukemia

EurekAlert! - Cancer  Thu, 06/11/2009 - 22:00

(Georgetown University Medical Center) A protein known to play a role in growth of some types of leukemia appears to have a mixed function in breast cancer development, say researchers from the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center.


 

Protein linked to change in tissue that surround and support bre...

EurekAlert! - Cancer  Thu, 06/11/2009 - 22:00

(Georgetown University Medical Center) A protein known to be overly active in breast cancer can exist in a form that seems to change the structural composition of mammary tissue, potentially making it more conducive to tumor progression, say researchers from the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center.


 

Lombardi scientist brings 'dream team' breast cancer research ef...

EurekAlert! - Cancer  Tue, 05/26/2009 - 22:00

(Georgetown University Medical Center) It's called a "Dream Team." Lombardi Comprehensive Cancer Center's incoming scientific director V.

Craig Jordan, O.B.E., Ph.D., D.Sc., and 12 of the nation's top breast cancer researchers have been awarded a multi-million dollar grant from Stand Up To Cancer to form a scientific "Dream Team".

This collaboration of the best and brightest scientists will conduct new breast cancer research with the goal of producing tangible research results benefiting patient care within three years.